SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-022436
Filing Date
2021-04-30
Accepted
2021-04-30 14:32:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ovid-defa14a_20210430.htm DEFA14A 31567
2 GRAPHIC g2f5vlhriijd000002.jpg GRAPHIC 153553
3 GRAPHIC g2f5vlhriijd000001.jpg GRAPHIC 210845
  Complete submission text file 0001564590-21-022436.txt   534400
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38085 | Film No.: 21876656
SIC: 2834 Pharmaceutical Preparations